There must have been quite a party in Rockville (Md., at FDA headquarters) last Thursday evening. Earlier that day, the U.S. Senate approved the FDA Amendments Act (FDAAA) of 2007 "without debate," and news organizations were quick to enumerate the new powers the Act would bring to the Agency. According to the Baltimore Sun, the Act gives FDA new authority to:
- Order warnings on drug labels
- Review drug ads before they air on television
- Make results of drug clinical trials available publicly
- Reduce the number of expert advisers with industry ties
- Require studies of new drugs' performance
- Probe patient databases for early signs of side effects
Latest from Home
Latest from Home